Form S-4 - Registration of securities, business combinations:
SEC Accession No. 0001047469-09-006543
Filing Date
2009-06-26
Accepted
2009-06-26 15:21:20
Documents
11

Document Format Files

Seq Description Document Type Size
1 S-4 a2193480zs-4.htm S-4 1804811
2 EXHIBIT 23.1 a2193480zex-23_1.htm EX-23.1 2782
3 EXHIBIT 23.2 a2193480zex-23_2.htm EX-23.2 2814
4 EXHIBIT 23.4 a2193480zex-23_4.htm EX-23.4 2818
5 EXHIBIT 99.3 a2193480zex-99_3.htm EX-99.3 27732
6 EXHIBIT 99.4 a2193480zex-99_4.htm EX-99.4 28680
7 EXHIBIT 99.6 a2193480zex-99_6.htm EX-99.6 5115
8 EXHIBIT 99.7 a2193480zex-99_7.htm EX-99.7 3562
9 G825671.JPG g825671.jpg GRAPHIC 12325
10 G347176.JPG g347176.jpg GRAPHIC 3908
11 G156842MQI001.GIF g156842mqi001.gif GRAPHIC 8208
  Complete submission text file 0001047469-09-006543.txt   1913986
Mailing Address 119 FOURTH AVE NEEDHAM MA 02494-2725
Business Address 119 FOURTH AVE NEEDHAM MA 02494 7814330771
Celldex Therapeutics, Inc. (Filer) CIK: 0000744218 (see all company filings)

EIN.: 133191702 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-4 | Act: 33 | File No.: 333-160257 | Film No.: 09912725
SIC: 2835 In Vitro & In Vivo Diagnostic Substances